BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37118834)

  • 1. Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors.
    Choi DW; Kang H; Zhang HS; Jhang H; Jeong W; Park S
    Cancer; 2023 Sep; 129(17):2705-2716. PubMed ID: 37118834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients.
    Chen LJ; Nguyen TNM; Chang-Claude J; Hoffmeister M; Brenner H; Schöttker B
    Oncologist; 2021 Dec; 26(12):e2170-e2180. PubMed ID: 34476870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effects of Frailty and Polypharmacy on Health Outcomes in Older Adults: Frailty Outweighs Polypharmacy.
    Chen YZ; Huang ST; Wen YW; Chen LK; Hsiao FY
    J Am Med Dir Assoc; 2021 Mar; 22(3):606.e7-606.e18. PubMed ID: 32873474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer.
    Park JW; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2016 May; 142(5):1031-40. PubMed ID: 26744323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib.
    Yekedüz E; Aktaş EG; Köksoy EB; Doğan N; Ürün Y; Utkan G
    Future Oncol; 2022 Mar; 18(9):1067-1076. PubMed ID: 35109668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study.
    Gutiérrez-Valencia M; Izquierdo M; Malafarina V; Alonso-Renedo J; González-Glaría B; Larrayoz-Sola B; Monforte-Gasque MP; Latasa-Zamalloa P; Martínez-Velilla N
    Geriatr Gerontol Int; 2017 Dec; 17(12):2354-2360. PubMed ID: 28422415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study.
    Toida T; Toida R; Takahashi R; Uezono S; Komatsu H; Sato Y; Fujimoto S
    Clin Exp Nephrol; 2021 Nov; 25(11):1215-1223. PubMed ID: 34129133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study.
    Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P
    J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty and polypharmacy in the community-dwelling elderly with multiple chronic diseases.
    Chuang YN; Chen CC; Wang CJ; Chang YS; Liu YH
    Psychogeriatrics; 2023 Mar; 23(2):337-344. PubMed ID: 36717278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
    Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
    Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.
    Filkova M; Carvalho J; Norton S; Scott D; Mant T; Molokhia M; Cope A; Galloway J
    J Rheumatol; 2017 Dec; 44(12):1786-1793. PubMed ID: 28966210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    Ratjen I; Schafmayer C; Enderle J; di Giuseppe R; Waniek S; Koch M; Burmeister G; Nöthlings U; Hampe J; Schlesinger S; Lieb W
    BMC Cancer; 2018 Nov; 18(1):1156. PubMed ID: 30466408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polypharmacy and health-related quality of life among cancer survivors in the United States.
    Babcock ZR; Kogut SJ; Vyas A
    J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients.
    Leger DY; Moreau S; Signol N; Fargeas JB; Picat MA; Penot A; Abraham J; Laroche ML; Bordessoule D
    J Geriatr Oncol; 2018 Jan; 9(1):60-67. PubMed ID: 28851511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?
    Domínguez-Alonso JA; Conde-Estévez D; Bosch D; Pi-Figueras M; Tusquets I
    Clin Transl Oncol; 2021 Jan; 23(1):65-73. PubMed ID: 32449126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients.
    Poudel A; Peel NM; Nissen LM; Mitchell CA; Gray LC; Hubbard RE
    J Am Med Dir Assoc; 2016 Aug; 17(8):767.e9-767.e13. PubMed ID: 27373672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department.
    van Dam CS; Labuschagne HA; van Keulen K; Kramers C; Kleipool EE; Hoogendijk EO; Knol W; Nanayakkara PWB; Muller M; Trappenburg MC; Peters MJL
    Eur Geriatr Med; 2022 Aug; 13(4):849-857. PubMed ID: 35723840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.